Thu, September 22, 2022
Wed, September 21, 2022
Tue, September 20, 2022
Mon, September 19, 2022
Fri, September 16, 2022
Thu, September 15, 2022
Wed, September 14, 2022
Tue, September 13, 2022
Mon, September 12, 2022
Fri, September 9, 2022

Reni Benjamin Initiated (BCAB) at Buy and Held Target at $17 on, Sep 15th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-17-on-sep-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Reni Benjamin of JMP Securities, Initiated "BioAtla, Inc." (BCAB) at Buy and Held Target at $17 on, Sep 15th, 2022.

Reni has made no other calls on BCAB in the last 4 months.



There are 2 other peers that have a rating on BCAB. Out of the 2 peers that are also analyzing BCAB, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $4 on, Wednesday, August 10th, 2022


This is the rating of the analyst that currently disagrees with Reni


  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Wednesday, August 10th, 2022

Publication Contributing Sources